Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Stockholders Equity of -$1.16 million for the year ending 2025.
- Cannabis Bioscience International Holdings, Inc. showed a decrease of -7.8% in Stockholders Equity from 2024 to 2025.
- This data is from Cannabis Bioscience International Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on September 22, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $62.16 million | Q4 2011: $69.67 million | Q1 2012: $69.33 million | Q3 2022: -$498.1 thousand | Q4 2022: -$405.3 thousand | Q1 2023: -$481.7 thousand | Q3 2023: -$717.5 thousand | Q4 2023: -$841.9 thousand | Q1 2024: -$976.1 thousand | Q2 2024: -$1.08 million | Q3 2024: -$1.06 million | Q4 2024: -$1.13 million | Q2 2025: -$1.16 million | Q3 2025: -$1.25 million | Q4 2025: -$1.36 million.
- Over the full 4 years of available data (2022 to 2025), Cannabis Bioscience International Holdings, Inc.'s Stockholders Equity has declined by 222.3%.
- Historical annual values: Fiscal year 2025: -$1.16 million | Fiscal year 2024: -$1.08 million | Fiscal year 2023: -$591.7 thousand | Fiscal year 2022: -$361.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: